2 Significant Positive Events Aren’t Enough to Fix the Market
A Treasury intervention and 170% move in Moderna produced only a 0.2% gain in the S&P 500.
Wednesday’s Tepid Rally Was Led by Defensive Issue
I’d have expected a bond market rally to give stocks more of a lift. But it didn’t. Does that mean we can expect more downside?
A Shift in Market Character, Not a Collapse
Sustained upside is less likely from here, as rotation is starting to turn defensive.
Is the Stock Market Due for an ‘Everything Day?’
We’ve been stuck in this either/or market for what seems like an eternity. Perhaps it’s time that everything moves together.
Kass: Welcome to the ‘Rosy Scenario.’ What Could Possibly Go Wrong?
We are at or approaching an important market top — and investors are under-appreciating the risks.
No Time to Let Your Guard Down
As tensions with Iran escalate, major domestic equity market indexes trade close to all-time highs, and oil rises, you best be ready.
4 Issues Are Colliding to Test a Vulnerable Market
Global yields are surging as chip strength reverses and negative seasonality beckons.
Is the S&P 500 Weaker Than Current Prices Would Have Us Believe?
I’m watching an increase in the number of new lows, and it’s not suggesting higher prices.
Of All Post-Earnings Worries, This One Keeps Me Up at Night
Fighting with Iran and threats the conflict could spread concern me. Another worry is Japan’s bond yields. But neither bother me as much as this.
A Small-Cap Stock Is Offering an Opportunity — And Almost Nobody Is Covering It
Amid ‘troubling’ market action Monday, here’s what to know about one of my top small-cap plays.